ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma

. 2021 Jan ; 31 (1) : 12-39. [epub] 20201218

Jazyk angličtina Země Velká Británie, Anglie Médium print-electronic

Typ dokumentu časopisecké články, směrnice pro lékařskou praxi, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid33397713

A European consensus conference on endometrial carcinoma was held in 2014 to produce multi-disciplinary evidence-based guidelines on selected questions. Given the large body of literature on the management of endometrial carcinoma published since 2014, the European Society of Gynaecological Oncology (ESGO), the European SocieTy for Radiotherapy and Oncology (ESTRO), and the European Society of Pathology (ESP) jointly decided to update these evidence-based guidelines and to cover new topics in order to improve the quality of care for women with endometrial carcinoma across Europe and worldwide.

Clinical Research Unit Institut Bergonie Bordeaux France

Department of Gynaecologic Oncology Imperial College London Faculty of Medicine London UK

Department of Gynaecology Royal Marsden Hospital London UK

Department of Gynecology and Obstetrics Gynecologic Oncology Leuven Cancer Institute Catholic University Leuven Leuven Belgium

Department of Gynecology and Obstetrics Innsbruck Medical University Innsbruck Austria

Department of Gynecology and Obstetrics TU Dresden Medizinische Fakultat Carl Gustav Carus Dresden Germany

Department of Gynecology with Center for Oncological Surgery Campus Virchow Klinikum Charité Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin Humboldt Universität zu Berlin and Berlin Institute of Health Berlin Germany

Department of Medical Oncology Amsterdam University Medical Centres Amsterdam Noord Holland Netherlands

Department of Medical Oncology Clinica Universidad de Navarra Madrid Spain

Department of Medical Oncology St James Hospital Dublin Ireland

Department of Obstetrics and Gynecologic Oncology University Hospital Strasbourg France

Department of Obstetrics and Gynecology 1st Faculty of Medicine Charles University General University Hospital Prague Prague Czech Republic

Department of Obstetrics and Gynecology Innsbruck Medical University Innsbruck Austria

Department of Oncology Rigshospitalet Copenhagen University Hospital Copenhagen Denmark

Department of Pathology Hospital Graz 2 Graz Austria

Department of Pathology Hospital Universitari Arnau de Vilanova University of Lleida CIBERONC Irblleida Spain

Department of Pathology Hospital Universitari de Bellvitge University of Barcelona Idibell Spain

Department of Pathology Leids Universitair Medisch Centrum Leiden Netherlands

Department of Radiation Oncology Comprehensive Cancer Center Christian Doppler Laboratory for Medical Radiation Research for Radiation Oncology Medical University of Vienna Vienna Austria

Department of Radiation Oncology Institut Gustave Roussy Villejuif France

Department of Radiation Oncology Leiden University Medical Center Leiden Netherlands

Department of Radiation Oncology Medical Faculty of the University of Cologne Cologne Germany

Department of Radiotherapy Erasmus MC Cancer Institute Rotterdam Netherlands

Department of Surgery Institut Gustave Roussy Villejuif France

Division of Gynecologic Oncology Fondazione Policlinico Universitario A Gemelli IRCCS Rome Italy

Evangelische Kliniken Essen Mitte Essen Germany

Gynecologic Oncology Program European Institute of Oncology IRCCS Milan and University of Milan Bicocca Milan Italy

Histopathology and Molecular Diagnostics Azienda Ospedaliero Universitaria Careggi Florence Italy

School of Medicine Johannes Kepler University Linz Linz Austria

UCL Cancer Institute University College London UK

Komentář v

PubMed

Komentář v

PubMed

Komentář v

PubMed

Citace poskytuje Crossref.org

Nejnovějších 20 citací...

Zobrazit více v
Medvik | PubMed

Next-generation sequencing in the molecular classification of endometrial carcinomas: Experience with 270 cases suggesting a potentially more aggressive clinical behavior of multiple classifier endometrial carcinomas

. 2024 Dec 15 ; () : . [epub] 20241215

Efficacy of Single- and Dual-Docking Robotic Surgery of Paraaortic and Pelvic Lymphadenectomy in High-Risk Endometrial Cancer

. 2024 Apr 23 ; 14 (5) : . [epub] 20240423

Staging by imaging in gynecologic cancer and the role of ultrasound: an update of European joint consensus statements

. 2024 Mar 04 ; 34 (3) : 363-378. [epub] 20240304

Preoperative CA125 Significantly Improves Risk Stratification in High-Grade Endometrial Cancer

. 2023 May 04 ; 15 (9) : . [epub] 20230504

Relevance of Molecular Profiling in Patients With Low-Grade Endometrial Cancer

. 2022 Dec 01 ; 5 (12) : e2247372. [epub] 20221201

External validation study of endometrial cancer preoperative risk stratification model (ENDORISK)

. 2022 ; 12 () : 939226. [epub] 20220803

Does an Endometrial Cancer Diagnosis among Asymptomatic Patients Improve Prognosis?

. 2021 Dec 27 ; 14 (1) : . [epub] 20211227

New Trends in the Detection of Gynecological Precancerous Lesions and Early-Stage Cancers

. 2021 Dec 17 ; 13 (24) : . [epub] 20211217

Tumor Characteristic Variations between Symptomatic and Asymptomatic Endometrial Cancer

. 2021 Jul 16 ; 9 (7) : . [epub] 20210716

The Clinical Significance of DJ1 and L1CAM Serum Level Monitoring in Patients with Endometrial Cancer

. 2021 Jun 15 ; 10 (12) : . [epub] 20210615

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...